المؤلفون: Bożena Cybulska-Stopa, Barbara Ziółkowska, Łukasz Galus, Tomasz Kubiatowski, Stanisław Kieszko, Karolina Piejko, Jacek Mackiewicz, Piotr Rutkowski, Anna Drosik-Kwaśniewska, Jacek Calik, Grażyna Kamińska-Winciorek, Marcin Ziętek, Anna M. Czarnecka, Renata Pacholczak-Madej, Paweł Rogala, Katarzyna Gajewska-Wicher, Rafał Suwiński, Janusz Rolski, Agata Sałek-Zań, Natasza Kempa-Kamińska

المصدر: Immunotherapy. 13:297-307

مصطلحات موضوعية: Adult, Male, Oncology, medicine.medical_specialty, Multivariate analysis, Drug-Related Side Effects and Adverse Reactions, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Immunology, Pembrolizumab, Antibodies, Monoclonal, Humanized, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Humans, Immunology and Allergy, Medicine, 030212 general & internal medicine, Stage (cooking), Adverse effect, Immune Checkpoint Inhibitors, Melanoma, Aged, Retrospective Studies, Aged, 80 and over, business.industry, Immunotherapy, Middle Aged, Prognosis, medicine.disease, Progression-Free Survival, Survival Rate, Clinical trial, Nivolumab, Treatment Outcome, 030220 oncology & carcinogenesis, Female, Poland, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75481f1f9c5cc0cca549a49f8bad084dTest
https://doi.org/10.2217/imt-2020-0217Test

المؤلفون: Adrian Muenscher, Philippe Schafhausen, Henrike Barbara Zech, Nikolaus Moeckelmann, Mascha Binder, Arne Boettcher, Christian Stephan Betz, Chia-Jung Busch, Eik Vettorazzi, Carsten Bokemeyer

المصدر: Future Oncology. 16:3035-3043

مصطلحات موضوعية: Adult, Male, Oncology, Cancer Research, medicine.medical_specialty, Mitomycin, Programmed Cell Death 1 Receptor, Ipilimumab, Disease-Free Survival, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, law, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Adjuvant therapy, Clinical endpoint, Humans, Medicine, CTLA-4 Antigen, Prospective Studies, 030223 otorhinolaryngology, Immune Checkpoint Inhibitors, Neoplasm Staging, Squamous Cell Carcinoma of Head and Neck, business.industry, Head and neck cancer, Chemoradiotherapy, Adjuvant, General Medicine, Middle Aged, medicine.disease, Head and neck squamous-cell carcinoma, Neoadjuvant Therapy, Clinical trial, stomatognathic diseases, Nivolumab, Chemotherapy, Adjuvant, Head and Neck Neoplasms, 030220 oncology & carcinogenesis, Female, Fluorouracil, Cisplatin, Neoplasm Recurrence, Local, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41f2b4123f6aefe3592460ca34f1940eTest
https://doi.org/10.2217/fon-2020-0595Test

المؤلفون: Sebastian Haferkamp, Florian Scholz, Hartmut Richter, Victoria Banks, Peter Mohr, Katarina Öhrling, Karly S. Louie

المصدر: Future Oncology. 16:317-328

مصطلحات موضوعية: Adult, Male, Cancer Research, medicine.medical_specialty, Volume Administered, Databases, Factual, Patient characteristics, Herpesvirus 1, Human, Kaplan-Meier Estimate, 030207 dermatology & venereal diseases, 03 medical and health sciences, 0302 clinical medicine, Prescription database, Germany, Internal medicine, medicine, Humans, Summary of Product Characteristics, Medical prescription, Melanoma, Aged, Retrospective Studies, Aged, 80 and over, Oncolytic Virotherapy, Biological Products, business.industry, Retrospective cohort study, General Medicine, Guideline, Middle Aged, Prognosis, Combined Modality Therapy, Oncolytic Viruses, Treatment Outcome, Oncology, 030220 oncology & carcinogenesis, Female, Talimogene laherparepvec, business, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c95bbaa7aa6794049cfd27431febefc9Test
https://doi.org/10.2217/fon-2019-0838Test

المؤلفون: Maria Teresa Fierro, Virginia Caliendo, Simone Ribero, Simona Osella-Abate, Martina Sanlorenzo, Ottavia Malavenda, Pietro Quaglino, Paolo Fava, Chiara Astrua, Elena Marra

المصدر: Future Oncology. 15:133-139

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, Skin Neoplasms, MAP Kinase Kinase 1, combination therapy, 0302 clinical medicine, Piperidines, Antineoplastic Combined Chemotherapy Protocols, Oximes, MEK inhibitors, Complete response, Aged, 80 and over, Trametinib, Melanoma, Imidazoles, BRAF inhibitors, General Medicine, Middle Aged, Treatment Outcome, 030220 oncology & carcinogenesis, Female, medicine.drug, Adult, Proto-Oncogene Proteins B-raf, medicine.medical_specialty, Metastatic melanoma, Combination therapy, Pyridones, melanoma, Pyrimidinones, 03 medical and health sciences, Internal medicine, medicine, Humans, In patient, Protein Kinase Inhibitors, Aged, Retrospective Studies, business.industry, Dabrafenib, medicine.disease, 030104 developmental biology, Survival benefit, Vemurafenib, Mutation, Azetidines, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5fa36af49f03985cb916fae76f51f9fTest
https://doi.org/10.2217/fon-2018-0386Test

المؤلفون: Maria Pia Foschini, Giuseppe Lamberti, S. Minichillo, Enrico Di Oto, Alexandro Paccapelo, Daniela Bartolini, Andrea Lanese, Antonella Mura, Alicia Tosoni, E. Zunarelli, Stefano Pizzolitto, Enrico Franceschi, Alba A. Brandes, Daniela Danieli, Giovanni Lanza, Dario de Biase, Annalisa Pession, Michela Visani, Enrico Maria Silini, Giovanni Tallini, Stefania Bartolini

المساهمون: Franceschi E, Mura A, De Biase D, Tallini G, Pession A, Foschini MP, Danieli D, Pizzolitto S, Zunarelli E, Lanza G, Bartolini D, Silini EM, Visani M, Di Oto E, Tosoni A, Minichillo S, Lamberti G, Lanese A, Paccapelo A, Bartolini S, Brandes AA

المصدر: Future Oncology. 14:1559-1567

مصطلحات موضوعية: Male, Oncology, Cancer Research, Multivariate analysis, medicine.medical_treatment, Neurosurgical Procedures, IDH 1/2, surgery, Cohort Studies, 0302 clinical medicine, Risk Factors, Medicine, MGMT methylation, DNA Modification Methylases, Univariate analysis, low-grade glioma, treatment, Brain Neoplasms, Glioma, General Medicine, Middle Aged, Prognosis, Isocitrate Dehydrogenase, Idh mutation, Chromosomes, Human, Pair 1, NGS, 030220 oncology & carcinogenesis, 1p19q co-deletion, IDH 1/2IDH mutation, low-grade gliomas, MGMT methylation, NGS, surgery, treatment, Female, Chromosome Deletion, Mgmt methylation, Risk assessment, Clinical risk factor, Adult, medicine.medical_specialty, Adolescent, low-grade gliomas, IDH 1/2IDH mutation, 1p19q co-deletion, Extent of resection, NO, 03 medical and health sciences, Internal medicine, Humans, Aged, business.industry, Tumor Suppressor Proteins, IDH mutation, Radiation therapy, DNA Repair Enzymes, Multivariate Analysis, Mutation, business, 030217 neurology & neurosurgery

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38c94c152974785bac440ab86d6ca414Test
https://doi.org/10.2217/fon-2017-0634Test

المؤلفون: Esther Oomen-de Hoop, Leni van Doorn, Anne Lenting, Ferry A.L.M. Eskens, Sander Bins, Ron H.N. van Schaik, Samira El Bouazzaoui, Ron H.J. Mathijssen

المساهمون: Medical Oncology, Clinical Chemistry

المصدر: Pharmacogenomics, 17(14), 1483-1490. Future Medicine Ltd.

مصطلحات موضوعية: Adult, Male, Niacinamide, 0301 basic medicine, Oncology, Sorafenib, medicine.medical_specialty, Genotype, Abcg2, Antineoplastic Agents, Pharmacology, Polymorphism, Single Nucleotide, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Genetics, Humans, Medicine, Glucuronosyltransferase, Aged, Retrospective Studies, biology, Liver-Specific Organic Anion Transporter 1, business.industry, Phenylurea Compounds, Liver Neoplasms, Middle Aged, medicine.disease, Multidrug Resistance-Associated Protein 2, digestive system diseases, Diarrhea, 030104 developmental biology, Treatment interruption, 030220 oncology & carcinogenesis, Hepatocellular carcinoma, Toxicity, biology.protein, Molecular Medicine, Female, medicine.symptom, business, SLCO1B1, Pharmacogenetics, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c97956b7127fa39e9116d1ccee26e59Test
https://doi.org/10.2217/pgs-2016-0063Test